Skip to main content
. 2021 Jul 23;6(10):2604–2616. doi: 10.1016/j.ekir.2021.07.015

Figure 1.

Figure 1

Study design. EOF, end of follow-up; EOT, end of treatment; ESA, erythropoiesis-stimulating agent; W, week.